Bacterial Vaginoses
16
2
2
9
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
12.5%
2 terminated out of 16 trials
81.8%
-4.7% vs benchmark
19%
3 trials in Phase 3/4
11%
1 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (16)
Multi-Gyn ActiGel Plus for Treatment of Bacterial Vaginosis
Vaginal Microbiome Transplantation for Recurrent Bacterial Vaginosis
Treatment of Bacterial Vaginosis Prior to Active Labor and Infectious Morbidity
A User Study With Vernivia® for Bacterial Vaginosis.
The Effect of Clindamycin and a Live Biotherapeutic on the Reproductive Outcomes of IVF Patients With Abnormal Vaginal Microbiota
A Randomized Controlled Trial of Treatment of Bacterial Vaginosis
The ASPIRE Trial - Aiming for Safe Pregnancies by Reducing Malaria and Infections of the Reproductive Tract
Estrogen, Probiotics and Vaginal Health to Prevent HIV Infection in ACB Women
Effects of Video-based Health Education on Maternal and Child Health in Ethiopia
Evaluation of a Novel Female Hygiene Device for Postcoital Discomfort
Vaginal Hygiene Wash as Adjunct Treatment in Bacterial Vaginosis
The Temporo-spatial Dynamics of Genital Tract Microbiota - an Observational Study in Oocyte Donors
Evaluate the Safety of a Single Oral Dose of Solosec™ (Secnidazole) 2g for the Treatment of Adolescent Girls With BV
Effects of Lactobacillus Pentosus KCA1 on the Gut and Vaginal Microbiome of Women With Bacterial Vaginosis
Treatment of BV With Donaxyl and a Molecular Test of Cure
Therapeutic Lactose to Support Vaginal Microbiota